Short-horizon event study estimation with a STAR model and real contaminated events

被引:3
|
作者
Andreou P.C. [1 ,2 ]
Louca C. [1 ,2 ]
Savva C.S. [1 ,3 ]
机构
[1] Department of Commerce, Finance and Shipping, Cyprus University of Technology, 115, Spyrou Araouzou Street, Lemesos
[2] Durham University Business School, Mill Hill Lane, Durham
[3] Centre for Growth and Business Cycle Research, University of Manchester, Manchester
关键词
Contaminated events; Event studies; Markov switching regression model; Smooth Transition Auto Regressive model; Test statistics;
D O I
10.1007/s11156-015-0515-3
中图分类号
学科分类号
摘要
We propose a test statistic for nonzero mean abnormal returns based on a Smooth Transition Auto Regressive (STAR) model specification. Estimation of STAR takes into account the probability of contaminated events that could otherwise bias the parameters of the market model and thus the specification and power of the test statistic. Using both simulated and real stock returns data from mergers and acquisitions, we find that the STAR test statistic is robust to contaminated events occurring in the estimation window and in the presence of event-induced increase in return variance. Under the STAR test statistic the true null hypothesis is rejected at appropriate levels. Moreover, it exhibits the highest levels of power when compared with other test statistics that are widely and routinely applied in short-horizon event studies. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:673 / 697
页数:24
相关论文
共 50 条
  • [31] Adverse events associated with inclisiran: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS)
    Li, Bing
    Chen, Yan
    Zhang, Yongyi
    Qian, Mengying
    Shan, Qing
    Qian, Jiao
    Guo, Jinmin
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [32] A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system
    Lin, Xiao-Na
    Zeng, You-Jie
    Cao, Si
    Jing, Xi-Bo
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [33] EDTA leaching of copper from contaminated soils: Experimental study and transport model application for parameters estimation
    Di Palma, L
    Ferrantelli, P
    Pitzolu, I
    Verdone, N
    ENVIRONMENTAL TECHNOLOGY, 2005, 26 (02) : 189 - 198
  • [34] Improved short-term stability for real-time GNSS satellite clock estimation with clock model
    Shengfeng Gu
    Feiyu Mao
    Xiaopeng Gong
    Yidong Lou
    Chuang Shi
    Journal of Geodesy, 2023, 97
  • [35] Improved short-term stability for real-time GNSS satellite clock estimation with clock model
    Gu, Shengfeng
    Mao, Feiyu
    Gong, Xiaopeng
    Lou, Yidong
    Shi, Chuang
    JOURNAL OF GEODESY, 2023, 97 (06)
  • [36] Optimization and Empirical Study of the STAR Model's Parameter Estimation with Armijo-type Line Search
    Tian Kun
    Wang Qin
    Chang Chunyan
    CONTEMPORARY INNOVATION AND DEVELOPMENT IN STATISTICAL SCIENCE, 2012, : 86 - 91
  • [37] Evaluation of Earthquake Magnitude Estimation and Event Detection Thresholds for Real-Time GNSS Networks: Examples from Recent Events Captured by the Network of the Americas
    Hodgkinson, Kathleen M.
    Mencin, David J.
    Feaux, Karl
    Sievers, Charles
    Mattioli, Glen S.
    SEISMOLOGICAL RESEARCH LETTERS, 2020, 91 (03) : 1628 - 1645
  • [38] Estimation of train dwell time at short stops based on track occupation event data: A study at a Dutch railway station
    Li, Dewei
    Daamen, Winnie
    Goverde, Rob M. P.
    JOURNAL OF ADVANCED TRANSPORTATION, 2016, 50 (05) : 877 - 896
  • [39] A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
    Wu, Shangrong
    Hu, Wenjin
    Chen, Mingzhe
    Xiao, Xiong
    Liu, Ranlu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Pulmonary adverse events associated with amiodarone: a real-world pharmacovigilance study based on the FDA adverse event reporting system
    Yang, Jingrong
    Zhang, Guangheng
    You, Mengfan
    Zhang, Han
    Shang, Yonghan
    Xing, Kaidi
    Ge, Deye
    Su, Wenge
    Wang, Yifei
    EXPERT OPINION ON DRUG SAFETY, 2024,